Biblio

33557 resultats trouvés
D
Compter A, Schilling S, Vaineau CJuliette, Goeggel-Simonetti B, Metso TM, Southerland A, Pezzini A, Kloss M, Touze E, Worrall BB et al..  2018.  Determinants and outcome of multiple and early recurrent cervical artery dissections. NEUROLOGY. 91:E769-E780.
Loupy A, Vernerey D, Viglietti D, Aubert O, van Huyen J-PDuong, Empana J-P, Bruneval P, Glotz D, Legendre C, Jouven X et al..  2015.  Determinants and Outcomes of Accelerated Arteriosclerosis Major Impact of Circulating Antibodies. CIRCULATION RESEARCH. 117:470-482.
Bazzicalupi C, Ferraroni M, Papi F, Massai L, Bertrand B, Messori L, Gratteri P, Casini A.  2016.  Determinants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD Investigation. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 55:4256-4259.
Fautrel B., Belhassen M., Hudry C., Woronoff M.-C, Gouyette N., Clement A., Van Ganse E., Tubach F..  2017.  DETERMINANTS OF 12-MONTHS PERSISTENCE IN ANKYLOSING SPONDYLITIS PATIENTS INITIATING SUBCUTANEOUS TNF-ALPHA INHIBITORS. ANNALS OF THE RHEUMATIC DISEASES. 76:754-755.
Fautrel B, Belhassen M, Hudry C, Woronoff M-C, Gouyette N, Clement A, Van Ganse E, Tubach F.  2017.  Determinants of 12-Months Persistence in Ankylosing Spondylitis Patients Initiating Subcutaneous TNF-alpha Inhibitors. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 26:514-515.
Fautrel B, Belhassen M, Hudry C, Woronoff M-C, Gouyette N, Clement A, Van Ganse E, Tubach F.  2017.  Determinants of 12-Months Persistence in Ankylosing Spondylitis Patients Initiating Subcutaneous TNF-alpha Inhibitors. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 26:514-515.
Fautrel B., Belhassen M., Hudry C., Woronoff M-C., Gouyette N., Clement A., Van Ganse E., Tubach F..  2017.  DETERMINANTS OF 12-MONTHS PERSISTENCE IN PSORIATIC ARTHRITIS PATIENTS INITIATING SUBCUTANEOUS TNF-ALPHA INHIBITORS. ANNALS OF THE RHEUMATIC DISEASES. 76:1034.
Fautrel B, Belhassen M, Hudry C, Woronoff M-C, Gouyette N, Clement A, Van Ganse E, Tubach F.  2017.  Determinants of 12-Months Persistence in Psoriatic Arthritis Patients Initiating Subcutaneous TNF-alpha Inhibitors. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 26:515-516.
Fautrel B, Belhassen M, Hudry C, Woronoff M-C, Gouyette N, Clement A, Van Ganse E, Tubach F.  2017.  Determinants of 12-Months Persistence in Psoriatic Arthritis Patients Initiating Subcutaneous TNF-alpha Inhibitors. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 26:515-516.
Fautrel B., Belhassen M., Hudry C., Woronoff M-C., Gouyette N., Clement A., Van Ganse E., Tubach F..  2017.  DETERMINANTS OF 12-MONTHS PERSISTENCE IN RHEUMATOID ARTHRITIS PATIENTS INITIATING SUBCUTANEOUS TNF-ALPHA INHIBITORS. ANNALS OF THE RHEUMATIC DISEASES. 76:1033-1034.
Fautrel B, Belhassen M, Hudry C, Woronoff M-C, Gouyette N, Clement A, Van Ganse E, Tubach F.  2017.  Determinants of 12-Months Persistence in Rheumatoid Arthritis Patients Initiating Subcutaneous TNF-alpha Inhibitors. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 26:514.
Fautrel B, Belhassen M, Hudry C, Woronoff M-C, Gouyette N, Clement A, Van Ganse E, Tubach F.  2017.  Determinants of 12-Months Persistence in Rheumatoid Arthritis Patients Initiating Subcutaneous TNF-alpha Inhibitors. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 26:514.
Sulmont-Rosse C, Van Wymelbeke V.  2019.  Determinants of a low protein intake in the institutionalized elderly people. CAHIERS DE NUTRITION ET DE DIETETIQUE. 54:180-189.
Resseguier N, Rosso-Delsemme N, Anzola ABeltran, Baumstarck K, Milien V, Ardillon L, Bayart S, Berger C, Bertrand M-A, Biron-Andreani C et al..  2018.  Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional study. BMJ OPEN. 8:e022409.
Gabet A, Grimaud O, de Peretti C, Bejot Y, Olie V.  2019.  Determinants of Case Fatality After Hospitalization for Stroke in France 2010 to 2015. STROKE. 50:305-312.
Clifford GM, Siproudhis L, Piroth L, Poizot-Martin I, Radenne S, Reynes J, Lesage A, Heard I, Henno S, Flejou J-F et al..  2018.  Determinants of high-grade anal intraepithelial lesions in HIV-positive MSM. AIDS. 32:2363-2371.
Tannoury J, Nachury M, Martins C, Serrero M, Filippi J, Roblin X, Bourrier A, Bouguen G, Franchimont D, Savoye G et al..  2021.  Determinants of IBD-related disability: a cross-sectional survey from the GETAID. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 53:1098-1107.
Puymirat E, Schiele F, Steg PGabriel, Blanchard D, Isorni M-A, Silvain J, Goldstein P, Gueret P, Mulak G, Berard L et al..  2014.  Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: Insights from the French FAST-MI program over 15 years. INTERNATIONAL JOURNAL OF CARDIOLOGY. 177:281-286.
Herve F, Manthe E, Sannajust A, Schwienbacher A.  2019.  Determinants of individual investment decisions in investment-based crowdfunding. JOURNAL OF BUSINESS FINANCE & ACCOUNTING. 46:762-783.
Its A.R, Kozlowski K.K.  2014.  On Determinants of Integrable Operators with Shifts. INTERNATIONAL MATHEMATICS RESEARCH NOTICES. 2014:6826-6838.
Rolland B, Trojak B, Nourredine M, Bachellier J, Chappuy M, Bendimerad P, Kosim M, Hjelmstrom P, Meroueh F, Nubukpo P et al..  2021.  Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone. DRUG AND ALCOHOL DEPENDENCE. 220:108492.
Abildtrup J, Hilal M, Piguet V, Schmitt B.  2018.  Determinants of local population growth and economic development in France between 1990 and 2006. REVUE D ECONOMIE REGIONALE ET URBAINE. :91-127.
Gayat E, Cariou A, Deye N, Vieillard-Baron A, Jaber S, Damoisel C, Lu Q, Monnet X, Rennuit I, Azoulay E et al..  2018.  Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study. CRITICAL CARE. 22:8.
Lamure S, Dulery R, Di Blasi R, Chauchet A, Laureana C, Deau-Fischer B, Drenou B, Soussain C, Rossi C, Noel N et al..  2020.  Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study. ECLINICALMEDICINE. 27:100549.
Bonnet N., Lafont A., Danchin N., Lamhaut L., Mock L., N. Teixeira DSantos, Goldstein P., Schiele F., Simon T., Puymirat E. et al..  2014.  Determinants of prehospital use of opioids in AMI patients and association with early outcomes. Results from the FAST-MI 2010 registry. EUROPEAN HEART JOURNAL. 35:835.

Pages